Position in OCUL
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,148,574
+$979,093 QoQ
Shares Held
135,605
+835.3% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vontobel Holding Ltd. holds $92,341,956 across 47 Biotechnology names. OCUL ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
83,380 | $37,232,503 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,794 | $22,247,395 | |
| 3 | MRNA |
Moderna, Inc.
|
163,422 | $8,301,837 | |
| 4 | BNTX |
BioNTech SE
|
93,107 | $8,275,350 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,476 | $1,811,842 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
17,872 | $1,327,174 | |
| 7 | MCRB |
Seres Therapeutics, Inc.
|
138,468 | $1,228,211 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
This page
|
135,605 | $1,148,574 |
All Filings in OCUL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,148,574 | 135,605 | Shares | Defined | 2026-05-08 | |
| 2025-09-30 | $169,481 | 14,498 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $164,116 | 17,685 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $79,046 | 10,784 | Shares | Defined | 2025-04-28 | |
| 2023-09-30 | $31,400 | 10,000 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $51,600 | 10,000 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $131,750 | 25,000 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $67,440 | 24,000 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||